Why the study?
CMR studies have presented conflicting results regarding the prevalence of COVID-19-associated myocarditis.
What are the CMR findings and predictors of proved myocarditis in adult patients with active COVID-19 infection and suspected acute myocarditis?
What are the CMR findings and predictors of proved myocarditis in adult patients with active COVID-19 infection and suspected acute myocarditis?
In post-COVID-19 patients with suspected myocarditis, CMR reveals a high prevalence of suspected and proved myocarditis, with chest pain, ferritin, and LAVI serving as significant predictors.
CMR may identify myocarditis in symptomatic post-COVID patients; leaves open true prevalence and clinical impact.
Background:Cardiovascular magnetic resonance (CMR) imaging, considered the gold standard for myocarditis diagnosis, presented conflicting results on the prevalence of COVID-19-associated myocarditis. Objective: This study aimed to describe CMR findings in patients with active COVID-19 infection within three months of infection and who had suspected acute myocarditis. Patients and Methods:This was a multi-center cross-sectional study that comprised adult patients with COVID-19 and clinical suspicion of associated myocarditis. Evaluation encompassed history, clinical examination, laboratory investigations, ECG, echocardiography, and CMR using the revised Lake Louise Criteria 2018 for myocarditis diagnosis.Participants (n=100) were divided into three groups based on CMR findings (Group I (n = 6); no myocarditis, Group II (n = 63); suspected myocarditis, and Group III; proved myocarditis. Notably, Group III (n = 31) exhibited distinct characteristics. Results: A multivariate analysis showed that chest pain, ferritin levels, and LAVI significantly predicted proved myocarditis after adjusting the other confounding factors. Conclusions: Active COVID-19 infection within three months showed a high prevalence of suspected and proved myocarditis, with specific characteristics in the proved myocarditis group.
No takes yet. Share an insight, caveat, or question.
A 2024 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: